Patent details
EP2662091 Title: Anti-P-selectin antibodies and methods of using the same to treat inflammatory diseases
Basic Information
- Publication number:
- EP2662091
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP131644031
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Anti-P-selectin antibodies and methods of using the same to treat inflammatory diseases
- French Title of Invention:
- Anticorps anti-P-sélectine et procédés pour les utiliser dans le traitement des maladies inflammatoires
- German Title of Invention:
- Anti-P-Selektin-Antikörper und Verfahren zu ihrer Verwendung für die Behandlung von Entzündungserkrankungen
- SPC Number:
-
LUC00201
Dates
- Filing date:
- 30/11/2007
- Grant date:
- 22/08/2018
- EP Publication Date:
- 13/11/2013
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 22/08/2018
- EP B1 Publication Date:
- 22/08/2018
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 30/11/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 23/11/2018
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
- Name:
- Oklahoma Medical Research Foundation
- Address:
- 825 N.E. 13th Street, Oklahoma City, OK 73104, United States (US)
History of Owners
- From:
- 16/11/2018
- To:
- 23/11/2018
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
- From:
- 15/08/2018
- To:
- 16/11/2018
- Name:
- Selexys Pharmaceuticals Corporation
- Address:
- 800 Research Parkway Suite 338, Oklahoma City OK 73104, United States (US)
Inventor
1
- Name:
- Alvarez, Richard
- Address:
- United States (US)
2
- Name:
- McEver, Rodger P.
- Address:
- United States (US)
3
- Name:
- Kawar, Ziad
- Address:
- United States (US)
Priority
- Priority Number:
- 872170 P
- Priority Date:
- 01/12/2006
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 39/395; C07K 16/28;
Publication
European Patent Bulletin
1
- Issue number:
- 201834
- Publication date:
- 22/08/2018
- Description:
- Grant (B1)
2
- Issue number:
- 201852
- Publication date:
- 26/12/2018
- Description:
- Transfer of Rights
3
- Issue number:
- 201851
- Publication date:
- 19/12/2018
- Description:
- Transfer of Rights
Annual Fees
- Annual Fee Due Date:
- 30/11/2026
- Annual Fee Number:
- 20
- Annual Fee Amount:
- 300 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 13/11/2025
- Last Annual Fee Paid Number:
- 19
- Last Annual Fee Paid Amount:
- 281 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|